Semi-Annual Consolidated Statement Of Income

株式会社PRISM BioLab - Filing #7289919

Concept 2023-10-01 to
2024-09-30
2023-10-01 to
2024-09-30
2023-10-01 to
2024-09-30
2023-10-01 to
2024-09-30
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
Semi-annual consolidated statement of income
Statement of income
Net sales
305,620,000 JPY
112,926,000 JPY
Cost of sales
145,080,000 JPY
32,620,000 JPY
Gross profit (loss)
160,539,000 JPY
80,305,000 JPY
Ordinary profit (loss)
-831,518,000 JPY
-497,550,000 JPY
Selling, general and administrative expenses
Depreciation
JPY
359,000 JPY
Selling, general and administrative expenses
942,931,000 JPY
577,174,000 JPY
Extraordinary income
99,000 JPY
JPY
Extraordinary losses
216,784,000 JPY
28,154,000 JPY
Profit (loss) before income taxes
-1,048,203,000 JPY
-525,704,000 JPY
Operating profit (loss)
-782,392,000 JPY
-496,868,000 JPY
Non-operating income
Interest income
356,000 JPY
19,000 JPY
Non-operating income
788,000 JPY
89,000 JPY
Income taxes - current
1,310,000 JPY
1,210,000 JPY
Non-operating expenses
Non-operating expenses
49,914,000 JPY
770,000 JPY
Income taxes
1,310,000 JPY
1,210,000 JPY
Profit (loss)
-1,049,514,000 JPY
-1,049,514,000 JPY
-1,049,514,000 JPY
-1,049,514,000 JPY
-526,914,000 JPY
-526,914,000 JPY
-526,914,000 JPY
-526,914,000 JPY
Extraordinary income
Gain on sale of non-current assets
99,000 JPY
JPY
Extraordinary losses
Impairment losses
216,784,000 JPY
28,151,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.